ACM
American Capital Management Portfolio holdings
AUM
$2.41B
This Quarter Return
+4.05%
1 Year Return
+30.54%
3 Year Return
+95.63%
5 Year Return
+145.94%
10 Year Return
+635.3%
AUM
$1.05B
AUM Growth
+$1.05B
(+3.3%)
Cap. Flow
+$18.4M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
44.38%
Holding
72
New
1
Increased
31
Reduced
24
Closed
–
Top Buys
| 1 |
Idexx Laboratories
IDXX
|
$17.5M |
| 2 |
ABCO
Advisory Board Co/The
ABCO
|
$10.3M |
| 3 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$3.33M |
| 4 |
HMSY
HMS Holdings Corp.
HMSY
|
$2.01M |
| 5 |
Dorman Products
DORM
|
$1.79M |
Top Sells
| 1 |
Bausch Health
BHC
|
$11.7M |
| 2 |
Manhattan Associates
MANH
|
$4.79M |
| 3 |
Icon
ICLR
|
$1.14M |
| 4 |
SEI Investments
SEIC
|
$1.06M |
| 5 |
TruBridge
TBRG
|
$932K |
Sector Composition
| 1 | Healthcare | 39.03% |
| 2 | Technology | 29% |
| 3 | Industrials | 8.14% |
| 4 | Financials | 7.97% |
| 5 | Consumer Discretionary | 6.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Manhattan Associates
MANH
$13B
| $80.1M | 7.63% | 1,343,475 -80,287 | -6% | -$4.79M |
|
|
2
Bausch Health
BHC
$2.74B
| $78.7M | 7.5% | 354,303 -52,800 | -13% | -$11.7M |
|
|
3
Icon
ICLR
$13.8B
| $50.7M | 4.83% | 753,985 -16,900 | -2% | -$1.14M |
|
4
Cognex
CGNX
$7.38B
| $41.8M | 3.98% | 867,975 -6,335 | -0.7% | -$305K |
|
5
Illumina
ILMN
$15.8B
| $41M | 3.9% | 187,600 +125 | +0.1% | +$27.3K |
|
6
Hologic
HOLX
$14.9B
| $38.2M | 3.64% | 1,003,635 -11,190 | -1% | -$426K |
|
7
Factset
FDS
$14.1B
| $36.7M | 3.5% | 226,040 -1,160 | -0.5% | -$189K |
|
|
8
Idexx Laboratories
IDXX
$51.8B
| $34M | 3.24% | 530,136 +273,078 | +106% | +$17.5M |
|
9
ResMed
RMD
$40.2B
| $32.8M | 3.12% | 581,480 +12,350 | +2% | +$696K |
|
10
LKQ Corp
LKQ
$8.39B
| $32M | 3.05% | 1,058,798 -16,602 | -2% | -$502K |
|
|
11
SEI Investments
SEIC
$10.9B
| $31.7M | 3.02% | 646,880 -21,710 | -3% | -$1.06M |
|
12
Zebra Technologies
ZBRA
$16.1B
| $31M | 2.95% | 278,890 -6,860 | -2% | -$762K |
|
13
Gentex
GNTX
$6.15B
| $30.4M | 2.89% | 1,850,280 +45,950 | +3% | +$755K |
|
14
Verint Systems
VRNT
$1.23B
| $28.9M | 2.75% | 475,635 +27,400 | +6% | +$1.66M |
|
15
Haemonetics
HAE
$2.63B
| $27.8M | 2.65% | 673,116 -7,094 | -1% | -$293K |
|
16
Jack Henry & Associates
JKHY
$11.9B
| $24.7M | 2.35% | 381,473 +3,088 | +0.8% | +$200K |
|
17
Nice
NICE
$8.73B
| $23.2M | 2.21% | 364,605 -6,340 | -2% | -$403K |
|
|
HMSY
18
DELISTED
HMS Holdings Corp.
HMSY
| $22.4M | 2.14% | 1,306,290 +116,880 | +10% | +$2.01M |
|
|
CPHD
19
DELISTED
Cepheid Inc
CPHD
| $20.9M | 1.99% | 342,430 -2,310 | -0.7% | -$141K |
|
|
AMRI
20
DELISTED
Albany Molecular Research Inc
AMRI
| $20.1M | 1.91% | 993,280 -4,010 | -0.4% | -$81.1K |
|
21
Pediatrix Medical
MD
$1.5B
| $19.5M | 1.86% | 263,530 +4,200 | +2% | +$311K |
|
|
ABCO
22
DELISTED
Advisory Board Co/The
ABCO
| $16.6M | 1.58% | 303,355 +188,310 | +164% | +$10.3M |
|
|
IPCM
23
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $16.5M | 1.58% | 298,715 -3,500 | -1% | -$194K |
|
24
Forrester Research
FORR
$186M
| $16M | 1.53% | 445,287 +15,597 | +4% | +$562K |
|
25
Morningstar
MORN
$11.1B
| $15M | 1.43% | 188,220 -3,930 | -2% | -$313K |
|